3-(4-OXO-4,5-DIHYDRO-THIAZOL-2-YLAMINO)-PROPIONIC ACID
- $200 - $874
- Product name: 3-(4-OXO-4,5-DIHYDRO-THIAZOL-2-YLAMINO)-PROPIONIC ACID
- CAS: 797027-57-7
- MF: C6H8N2O3S
- MW: 188.2
- EINECS:
- MDL Number:MFCD04113965
- Synonyms:TIMTEC-BB SBB010772;3-[(4-oxo-1,3-thiazol-2-yl)amino]propanoic acid;3-[(4-oxo-2-thiazolyl)amino]propanoic acid;3-[(4-oxothiazol-2-yl)amino]propanoic acid;BAS 07339640;ChemDiv3_006582;IDI1_024492;N-(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)-beta-alanine
3 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11055381
- Product description3-((4-Oxo-4,5-dihydrothiazol-2-yl)amino)propanoicacid 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number012372
- Product description3-(4-Oxo-4,5-dihydro-thiazol-2-ylamino)-propionic acid
- Packaging500mg
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number012372
- Product description3-(4-Oxo-4,5-dihydro-thiazol-2-ylamino)-propionic acid
- Packaging1g
- Price$308
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11055381 | 3-((4-Oxo-4,5-dihydrothiazol-2-yl)amino)propanoicacid 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 012372 | 3-(4-Oxo-4,5-dihydro-thiazol-2-ylamino)-propionic acid | 500mg | $200 | 2021-12-16 | Buy |
Matrix Scientific | 012372 | 3-(4-Oxo-4,5-dihydro-thiazol-2-ylamino)-propionic acid | 1g | $308 | 2021-12-16 | Buy |
Properties
Boiling point :390.1±44.0 °C(Predicted)
Density :1.61±0.1 g/cm3(Predicted)
pka :4.32±0.10(Predicted)
Density :1.61±0.1 g/cm3(Predicted)
pka :4.32±0.10(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|